RPS Scotland has named Fiona McIntyre as its new Policy and Practice Lead. With a background in hospital pharmacy, McIntyre will be responsible for policy
development and professional support at RPS Scotland, and is set to assume her new role in early October.
McIntyre will assume a leadership role for specific projects across Great Britain, collaborating with the Policy and Practice Leads in England and Wales, RPS
Scotland said in a statement. Her responsibilities include representing pharmacists in working groups and meetings, engaging with pharmacists and pharmacy
organisations, and supporting the RPS Director for Scotland.
"During my career in NHS Scotland, I have advocated for pharmacy teams whenever possible," said McIntyre. "I am passionate about the profession's role in the
safe and effective use of medicines, and I'm privileged to join the RPS. I look forward to promoting pharmacy in Scotland and helping our profession reach its
full potential."
"I'm pleased that Fiona will be joining the RPS Scotland team as our policy lead," said Laura Wilson, Director for RPS Scotland. "Fiona's experience will be
invaluable to the role, and the whole team looks forward to her starting with us in October."
The Royal Pharmaceutical Society (RPS) has appointed Laura Wilson as Director for Scotland commencing 23rd January 2023.
Laura, is currently Policy and Practice Lead for RPS in Scotland. She is accountable for bringing national RPS policy to life for members in Scotland, while
contributing to the GB wide professional leadership agenda.
She will work closely with the Scottish Pharmacy Board, senior NHS officials and other key stakeholders across the breadth of the pharmacy profession and beyond
to ensure pharmacy is on the forefront of healthcare in Scotland.
She joins the existing team of RPS Country Directors, which includes Elen Jones, Director for Wales and James Davies, Director for England and will report directly
to the Chief Executive.
Laura Wilson said: "I am delighted to be appointed Director for Scotland having worked as part of the RPS Scotland team as the policy and practice lead. It will
be an honour to continue the fantastic work started by former Director Clare Morrison to bring Pharmacy 2030, our vision for pharmacy in Scotland in the future,
to life and supporting pharmacy teams to deliver person centred care.
The Royal Pharmaceutical Society (RPS) has appointed James Davies as Director of England.
Davies will be joining RPS in January 2023 to drive professional leadership for the pharmacy profession in England, working with and for RPS members.
He'll lead on national policy development, professional advocacy and member engagement across England, in partnership with the English Pharmacy Board.
Davies said: "It's a privilege to take up this position within the RPS, the professional home of pharmacy. I have been a member of the RPS throughout my pharmacy
career, and that has helped me to continually drive excellence in pharmacy practice. I'm excited about delivering the current RPS strategy to ensure that pharmacy
is, and continues to be, at the forefront of healthcare. I'm eager to work as part of the team and with the Board, leading and developing opportunities for the
profession that improve the lives of patients and the public.
The Royal Pharmaceutical Society (RPS) Wales and the Association of the British Pharmaceutical Industry (ABPI) co-hosted a drop-in session to inform members
of the Senedd (MSs) about the action taken by pharmacists to make medicines use more sustainable.
At a 'drop-in' session the ABPI, RPS members and staff had the opportunity to speak to a number of MSs from all political parties.
"With medicines accounting for around 25 per cent of the NHS carbon emissions, conversations were based around the key recommendations to reverse this from the RPS'
policies on sustainability," said RPS.
The three key themes emphasised in all discussions were- the need to educate the public and change behaviours to avoid stockpiling medicines; How the clinical skills
of prescribing pharmacists can be used for appropriate de-prescribing and switching patients to low carbon options; and importance of tackling waste.
RPS Wales Director Elen Jones said: "It was fantastic to see how interested and engaged the politicians were around these important issues. By the end of our
conversations, they all clearly understood and supported the importance of pharmacy leadership in this area, as well as the need for the link between climate
change and medicines to be better understood by patients.
The Royal Pharmaceutical Society has appointed communications agency to lead a review into how it can develop and strengthen member participation.
"We've appointed communications consultancy Luther Pendragon to carry out an independent review of the participation of members and of our communications
concerning decisions we take on behalf of the profession through our Governance boards," the Society said in a statement on Tuesday (May 10).
It added that review would examine how RPS members, elected members and stakeholders can feel engaged, informed and empowered to influence decisions about RPS policy and understand why decisions around organisational policy have been taken on their behalf by elected representatives.
It will also ensure RPS decision-making processes are open and transparent with an emphasis on evidence-based decision making, and recommend ways elected members are enabled to be publicly accountable for decisions taken by the organisation at Board and Assembly level.
A member of the English Pharmacy Board and RPS Assembly, Sharon Isobel Tait Buckle (also known as Sibby) has been elected unopposed as the treasurer of the
Royal Pharmaceutical Society (RPS).
Sibby takes over the role from Andre Yeung, whose tenure ended in June 2022.
Sibby was first elected to the English board in 2012 and is the first woman to hold the post since RPS became the professional leadership body in 2010. She is
already part of the Finance and Investment Committee, where RPS budgets, pensions, assets, financial priorities and performance, reserves and investment policies
are scrutinised and agreed.
Commenting on her new role, Buckle said: "I want to build on the great contribution made by our previous Treasurer. Over the next two years of my tenure I will
monitor and challenge our financial performance, our focus on Environmental, Social and Governance factors (ESG), investment strategy and performance and our
financial governance.
NHS England has commissioned the Royal Pharmaceutical Society (RPS) to develop guidance that helps community and hospital pharmacy teams across Britain to
reduce the impact of pharmacy services, pharmaceutical care and medicines on the environment.
The RPS said the Greener Pharmacy Guidance will enable pharmacies to self-assess their impact against the standards, benchmark and improve through evidence-based
activities and actions.
"I'm delighted our strong commitment to helping pharmacy reduce its environmental impact can now be taken to the next level through developing guidance and
accreditation for pharmacy teams," RPS president Professor Claire Anderson said.
"Medicines account for 25 per cent of carbon emissions within the NHS and this initiative underscores our commitment to promoting sustainable healthcare and
supporting the NHS's goal of achieving 'net zero' emissions by 2040."
Peter Morgan, medicines assistant director at NHS England, commented: "Pharmacy staff are involved in the purchasing and dispensing of almost every medicine used
in the NHS and the new Greener Pharmacy Guidance and Self-accreditation scheme will provide support for pharmacy professionals by outlining clear actions to deliver
more environmentally sustainable pharmacy practices."
The RPS said the guidance and digital self-assessment toolkit will integrate with carbon calculator tools to help pharmacy teams to measure their carbon footprint,
action plan to reduce use of carbon and improve sustainability.
The Taskforce report recognises the important role of community pharmacy and pharmacy teams, and in particular, the fact that they often have most contact with
individuals who are receiving medication assisted treatment, commented the Royal Pharmaceutical Society (RPS) on the publication of the Scottish Drug Deaths
Taskforce's final report.
The final report published on Thursday (June 21) follows four years of work developing and implementing a programme of actions to tackle the rising number of drug
deaths in Scotland.
RPS, as pharmacy's professional leadership body in Scotland and the rest of Great Britain, has positively engaged with the Taskforce as it carried out its work.
Last year, RPS published 'Pharmacy's role in reducing harm and preventing drugs deaths (Scotland)' which contained 14 key recommendations. Many of the recommended actions within the Taskforce's report align with RPS policy.
The Royal Pharmaceutical Society (RPS), professional membership body for pharmacists and pharmacy, has published its manifesto for the general election,
highlighting key issues facing the next government after the election on July 4.
Local candidates are urged to recognise and support the vital role pharmacists play in supporting people's health.
The RPS teams are gearing up to influence government policy in various crucial areas. Their key asks include:
Ensuring Secure Patient Access to Medicines
Supporting a Better-Connected NHS
Enhancing Accessible Prescribing in Local Communities
Maximizing Health Improvement through Locally Accessible Pharmacy Teams
Supporting the Workforce to Deliver Patient Care
Unlocking the Potential of New Advances in Medicines
Supporting the UK's Global Position in Science and Research
Acknowledging the efforts of pharmacists and their teams, Professor Claire Anderson, President of the RPS, noted that they are "working incredibly hard to
maintain patient access to care amid workforce challenges, medicines shortages and financial pressures."
Royal Pharmaceutical Society (RPS) and the Royal College of General Practitioners in Scotland hosted an event celebrating the collaborative work of the health
professions and policy makers in Scotland on reducing the environmental harm from prescribing and medicines use.
To share priorities for the Scottish Government, Alpana Mair, Head of Effective Therapeutics and Prescribing spoke and National Clinical Director Jason Leitch
appeared virtually. Gillian MacKay MSP, Scottish Greens spokesperson for Health and Social Care also joined in-person.
Medicines account for around 25% of the NHS's carbon emissions and have an ecological impact when they enter our wastewater system or our rivers and oceans.
Tackling the impact of prescribing will be a key part of meeting the ambition of a net zero NHS Scotland by 2040 at the latest.
Together, RCGP Scotland and RPS have held two roundtable events on sustainable prescribing, and in June 2022, released a joint statement calling for a wide range
of actions, which was signed by the Academy of Medical Royal Colleges and Faculties in Scotland, the Royal College of Physicians of Edinburgh, the Royal College of
Anaesthetists, the College of Radiographers, Royal College of Nursing, Queen's Nursing Institute Scotland and Chartered Society of Physiotherapy.
Continuing the work of RPS at the International Forum on Quality and Safety in Healthcare, the event aims to mark an opportunity for health professionals and
decision makers alike to join a global movement of sustainability in healthcare, and pledge to continue the important work of cutting the climate impact of medicine
use while maintaining the highest level of patient care and safety.
The Royal Pharmaceutical Society (RPS) on Wednesday announced that it is spearheading a new project, which aims to delve into the root causes of the
growing challenge of medicines shortages across the United Kingdom and provide solutions to mitigate its impact on patients and pharmacy practice.
A newly formed advisory group, chaired by RPS Fellow Dr. Bruce Warner, is set to convene later this month. The group will have experts from primary and secondary
care, patient advocacy groups, the pharmaceutical industry, suppliers, regulatory bodies, governmental representatives, and NHS officials.
The group aims to formulate a robust report to provide expert thought leadership and support for the wider debate on UK policy. Their work will be informed by a
thorough literature review, stakeholder interviews, online RPS member events, and patient stories.
The Scottish government has appointed Christina McKelvie MSP as the new Minister for Drugs and Alcohol policy, following the resignation of Elena
Whitham MSP due to health reasons.
In a letter to the First Minister, Whitham said she was receiving treatment for post-traumatic stress, which had "greatly" affected her wellbeing.
Commenting on the news, Royal Pharmaceutical Society (RPS) Scotland thanked Whitham for supporting them, particularly for her "efforts to bring in a new
national service to provide emergency access to supplies of naloxone."
RPS Scotland has continuously advocated for the accessibility of naloxone through all community pharmacies (for supply to people who use drugs, family, healthcare
professionals and carers), and to make it available in all clinical settings for use in emergencies.
It was also the top recommendation of their policy on Pharmacy's role in reducing harm and preventing drug deaths.
Royal Pharmaceutical Society (RPS) Scotland has submitted its evidence to the Health, Social Care and Sport Committee's inquiry into 'Healthcare in remote
and rural areas.'
The Committee had sought views on what policies and actions would be most effective in addressing the issues people face when accessing healthcare in these areas.
During the evidence session today (19 December), Laura Wilson, Director for RPS Scotland, highlighted the challenges faced by pharmacists and pharmacy in remote and
rural areas, as well as provided some of the solutions for ensuring a sustainable pharmacy workforce.
At present, people living in remote and rural areas of Scotland are required to travel to Glasgow or Aberdeen to undertake pharmacy training. Laura underscored the
need to develop alternative education and training pathways, such as "grow your own" models, to support remote and rural areas to develop and retain local pharmacists.
The Royal Pharmaceutical Society (RPS) has appointed Dr Amira Guirguis as the new Chair of its Science and Research Committee, effective from the New Year.
An accomplished pharmacist and renowned expert in substance misuse, Dr Guirguis was nominated by the RPS as a 'woman to watch' in 2020.
Previously, she has served as the Principal Investigator for the first Home Office-licensed Pharmacist-led drug checking service in the UK, and as the MPharm
Programme Director at Swansea University Medical School.
A PhD in Novel Psychoactive Substances (NPS) detection, she has made significant contributions to the field of pharmacy, to drug policy, and has won the 2014 JPAG
Geoffrey Phillips award for her groundbreaking research.
The Royal Pharmaceutical Society (RPS) in England has published a review of its 10-year Vision for Pharmacy Professional Practice that was launched in
December 2022 in collaboration with The King's Fund.
The 'one year on' vision report highlighted key milestones achieved in the first 12 months since its publication as well as opportunities for further progress.
It identified the publication of the NHS Long Term Workforce Plan, which recognises the significant role that pharmacists play in healthcare and commits to growing
and expanding the pharmacy workforce, as one of the positive policy developments made since the launch of the vision.
The development of a Vision for Community Pharmacy by Community Pharmacy England, the Nuffield Trust and The King's Fund; work on digital integration to enable
community pharmacists to update a clinical record; the launch of Pharmacy First scheme; and the publication of the public consultation of pharmacy supervision
were other key milestones mentioned in the report.
In a surprising move that has divided the pharmacy profession, the General Pharmaceutical Council (GPhC) has sanctioned hundreds of pharmacies to allow
patients to self-select certain Pharmacy (P) medicines, a decision met with strong opposition from the Royal Pharmaceutical Society (RPS) as well as from the
Pharmacy Defense Association (PDA).
In a statement, RPS shared that at a board meeting held on 19th June, they expressed "disappointment" over what they described as a lack of prior consultation
and comprehensive communication from the GPhC regarding the implications of this policy shift.
They argue that allowing patients to self-select certain P medicines could potentially jeopardize established professional guidelines and compromise the role of
pharmacists in ensuring safe medication use.
"Enabled by the General Pharmaceutical Council, we understand that hundreds of pharmacies, from large multiples to small independents, have been approved by the
regulator to enable patients to self-select certain P medicines," the statement said.
Laura Wilson, Director of the Royal Pharmaceutical Society (RPS) in Scotland discussed the future of the pharmacy workforce with Michael Matheson,
Cabinet Secretary for Health and Social Care at the SNP conference.
The event, which took place on 17 October in Aberdeen, Scotland featured other health officials including Colin Poolman, Director of the Royal College of
Nursing; Kenryck Lloyd-Jones, Public Affairs and Policy Manager for Scotland, Chartered Society of Physiotherapy; and Chris Marshall, Deputy Editor at Holyrood
Communications.
The Scottish government has recently unveiled its national workforce strategy for health and social care, laying out its plans for achieving recovery, growth,
and transformation.
Wilson highlighted the challenges and opportunities for the pharmacy workforce in Scotland to attract potential pharmacists into the profession and encourage
them to stay within the profession.
"This was a great opportunity to discuss with the Cabinet Secretary the challenges which exist for the pharmacy workforce in Scotland and to highlight some of
the solutions which need to be implemented to ensure a pharmacy workforce in Scotland which is fit for the future," she said.